Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Drug containment and delivery solutions provider SCHOTT Pharma has announced an investment of more than €100m ($114m) to ...

Given the scope of the risk, attention has turned to metabolic hormones that regulate appetite, satiety, and glucose metabolism, particularly glucagon-like peptide-1 (GLP-1). Its appetite ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are medicines that help the body lower blood sugar levels. They work ...

Over the past decade, the global pharmaceutical industry has witnessed a transformation in the treatment landscape for ...

Glucagon acts as a counterregulatory hormone, opposing insulin action and maintaining ... that of the extrapancreatic glucagon-related peptides. Working initially with anglerfish and later with ...

Monash University researchers have discovered how the hormone peptide glucagon could better ... which affect billions of people. Glucagon—like insulin, from the pancreas—has been known about ...

People with diabetes take insulin to lower high blood sugar ... Emergency treatment with the hormone glucagon (GCG) may be needed. Researchers at the University of California, Los Angeles ...

Plasma levels of the incretin glucagon-like peptide 1 (GLP-1 ... had pre- and postprandial hormone levels and insulin secretion rates (ISR) measured during a hyperglycemic clamp with either ...

When the Food and Drug Administration (FDA) approved Byetta (exenatide) in 2005, doctors thought it was just approving the ...

Long-acting GLP-1 RAs approved for use in the United States include: Glucagon-like peptide-1 (GLP-1) is a hormone that plays ... 1 RA is prescribed along with insulin, it can increase the odds ...

For instance, Motilin, a peptide hormone ... it is thought that GLP-1 (glucagon-like peptide-1) might interact with the gut microbiota to modulate metabolic processes. GLP-1 is believed to influence ...